Remove 2006 Remove Animal Testing Remove Pharmaceuticals
article thumbnail

Why have medicines progressed so little in the last decades?

Drug Discovery World

Dr Pandora Pound , Fellow Oxford Centre for Animal Ethics explores the hinderances of animal testing in pharma and why new technologies such AI, genomics and synthetic biology c an further drug development. ATLA Altern to Lab Anim. Clinical Development Success Rates 2006-2015.; 2009;37(SUPPL.

article thumbnail

Analysis Life Sciences Thank You FDA finalizes new guidance on nonclinical assessment of potential immunotoxicity

Agency IQ

The guidance looks very different from the draft that was published in February 2020, including changes in the scope of the guidance, its sponsorship, and the removal of all mentions of nonhuman primates for animal testing. Nonclinical studies encompass much more than just animal studies.

FDA 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Article Periodic Thank You Commission unveils “one substance, one assessment” reform package

Agency IQ

This also has clear potential to reduce animal testing, another key commitment made by the Commission. The Commission draws an analogy between the restriction and exemption process found in RoHS to the authorization and restriction processes (titles VII and VIII, respectively) found in the REACH Regulation (1907/2006/EC).

article thumbnail

Analysis Life Sciences Thank You The 53 regulations that FDA is currently working on

Agency IQ

For example, the FDA does not have a proposed rule listed that would change how it regulates animal testing requirements following the passage of the FDA Modernization Act 2.0 It’s also interesting to see what isn’t on this list. provisions of the Food and Drug Omnibus Reform Act (FDORA) in 2022. and the E.C.